Keith Michael Sullivan, MD

Professor of Medicine
James B. Wyngaarden Professor of Medicine, in the School of Medicine
Member of the Duke Cancer Institute
Campus mail Box 3961 Med Ctr, Durham, NC 27710
Phone (919) 668-1000
Email address sulli025@mc.duke.edu

Research areas

  • Late effects of cancer treatment and stem cell transplantation 
  • Chronic graft-versus-host disease 
  • Transplantation for sickle cell and autoimmune diseases 
  • Knowledge engineering

Overview
Early on, Dr. Sullivan and the team at Fred Hutchinson Cancer Research Center developed a systematic investigative approach for the diagnosis and treatment of chronic graft-versus-host disease (GVHD), the major cause of late morbidity and non-relapse mortality following allogeneic stem cell transplantation (SCT). As a result of this work, it became clear that blood and marrow transplant recipients require systematic long-term follow-up to evaluate and treat late complications of high-dose chemoradiotherapy and SCT.

The program grew into a large multidisciplinary team, resulting in improvement in patient outcome and quality of life. Through the late events project, he also contributed to outcomes research, computer decision support systems, and knowledge engineering for follow-up care. With quality of life as a focus, research pursued the application of SCT to diseases with high morbidity but little immediate mortality. For young patients with advanced, symptomatic sickle cell disease, myeloablative conditioning and SCT from an HLA-identical sibling has led to an 86% long-term survival free of sickle cell disease. For individuals with autoimmune diseases such as multiple sclerosis, scleroderma, and systemic lupus erythematosus, current therapy is often incomplete and significant morbidity from the disease or its treatment is observed.

Recent preclinical and clinical data suggest that high-dose immunosupression and SCT can halt the progression and, in some settings, reverse the course of autoimmune diseases. Since his arrival at Duke University, over 30 centers nationwide are participating in Duke-led phase II and III trials to test the toxicity, efficacy, and quality of life following autologous and allogeneic stem cell transplantation for autoimmune diseases.

These trials will also serve as platforms to study the immune repertoire and mechanistic pathways before and after SCT to gain greater insight into the basic mechanisms of autoimmunity.

A national repository of tissue and cell specimens is also part of these NIH-supported trials to further promote scientific study from these unique patients.

In Their Words

Education and Training

  • M.D., Indiana University at Indianapolis, 1971

Publications

Furst, DE, McSweeney, PA, Crofford, LJ, McDonagh, KT, Sullivan, KM, Mayes, MD, Nelson, JL, Gooley, TA, Holmberg, LA, Chen, CS, Wener, MH, Lee, J, Henstorf, G, Abidi, M, and Nash, RA. "High-Dose Immunosuppressive Therapy (HDIT) for SSc: Results of 3 year follow-up demonstrate continued improvement in function and skin with stability in the lungs." September 2004.

Scholars@Duke

Chao, NJ, Koh, L-P, Long, GD, Gasparetto, C, Horwitz, M, Morris, A, Lassiter, M, Sullivan, KM, and Rizzieri, DA. "Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens." Biol Blood Marrow Transplant 10, no. 8 (August 2004): 569-575.

PMID
15282535
Full Text

Wang, PP, and Sullivan, KM. "Medical expert systems." Information Sciences 162, no. 2 (May 17, 2004): 63-64.

Full Text

Nishimura, J-I, Kanakura, Y, Ware, RE, Shichishima, T, Nakakuma, H, Ninomiya, H, Decastro, CM, Hall, S, Kanamaru, A, Sullivan, KM, Mizoguchi, H, Omine, M, Kinoshita, T, and Rosse, WF. "Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan." Medicine 83, no. 3 (May 2004): 193-207.

PMID
15118546
Full Text

Furst, DE, Nash, R, Sullivan, KM, Saccardi, R, and McSweeney, P. "High dose immunotherapy with stem cell rescue in severe systemic sclerosis: An idea that is moving forward." Journal of Rheumatology 31, no. 12 (2004): 2331-2335.

PMID
15570631
Scholars@Duke

Bichindaritz, I, Moinpour, C, Kansu, E, Donaldson, G, Bush, N, and Sullivan, KM. "Case based reasoning for medical decision-support in a safety critical environment." Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 2780 LNAI (December 1, 2003): 314-323.

Full Text

Woodard, JP, Cunningham, JM, Sullivan, KM, Kamani, NR, and Walters, MC. "Bronchiolitis obliterans organizing pneumonia (BOOP) after bone marrow transplantation (BMT) for sickle cell disease (SCD): Association with acute chest syndrome (ACS)." November 16, 2003.

Scholars@Duke

Nash, RA, Bowen, JD, McSweeney, PA, Pavletic, SZ, Maravilla, KR, Park, M-S, Storek, J, Sullivan, KM, Al-Omaishi, J, Corboy, JR, DiPersio, J, Georges, GE, Gooley, TA, Holmberg, LA, LeMaistre, CF, Ryan, K, Openshaw, H, Sunderhaus, J, Storb, R, Zunt, J, and Kraft, GH. "High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis." Blood 102, no. 7 (October 2003): 2364-2372.

PMID
12763935
Full Text

Nash, RA, Dansey, R, Storek, J, Georges, GE, Bowen, JD, Holmberg, LA, Kraft, GH, Mayes, MD, McDonagh, KT, Chen, C-S, Dipersio, J, Lemaistre, CF, Pavletic, S, Sullivan, KM, Sunderhaus, J, Furst, DE, and McSweeney, PA. "Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 9, no. 9 (September 2003): 583-591.

PMID
14506660
Full Text

Chen, C-S, Boeckh, M, Seidel, K, Clark, JG, Kansu, E, Madtes, DK, Wagner, JL, Witherspoon, RP, Anasetti, C, Appelbaum, FR, Bensinger, WI, Deeg, HJ, Martin, PJ, Sanders, JE, Storb, R, Storek, J, Wade, J, Siadak, M, Flowers, MED, and Sullivan, KM. "Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation." Bone Marrow Transplantation 32, no. 5 (September 2003): 515-522.

PMID
12942099
Full Text

Pages